Unexpected Drug-Induced Liver Injury Associated With MenoFit: A Synbiotic Menopause Supplement-Reference-Cited by-同舟云学术

Unexpected Drug-Induced Liver Injury Associated With MenoFit: A Synbiotic Menopause Supplement

Published:2023-09 Issue:9 Volume:10 Page:e01153
ISSN:2326-3253
Container-title:ACG Case Reports Journal
language:en
Short-container-title:ACG Case Rep J

Author:

Dadlani Apaar¹²^ORCID,Anudu Azubuogu¹²,Marginean E. Celia³

Affiliation:

1. Section of Gastroenterology and Hepatology, Margaret M. and Albert B. Alkek Department of Medicine, Baylor College of Medicine, Houston, TX

2. Division of Abdominal Transplantation, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX

3. Department of Pathology and Immunology, Baylor St. Luke's Hospital, Baylor College of Medicine, Houston, TX

Abstract

ABSTRACT MenoFit is a widely available over-the-counter synbiotic supplement, which is marketed for use in relieving menopausal symptoms. So far, there is no published data on liver injury because of its use. We present the first reported case of MenoFit-induced liver injury in a patient who presented with 1 week of jaundice and abnormal liver biochemical tests in the absence of other risk factors and negative comprehensive workup for known etiologies of liver disease.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference15 articles.

1. Liver injury from herbal and dietary supplements;Navarro;Hepatology,2017

2. Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network;Navarro;Hepatology,2014

3. Gut microbiota and drug-induced liver injury: An update;Niu;Chin Med J (Engl),2020

4. Botanicals and hepatotoxicity;Roytman;Clin Pharmacol Ther,2018

5. Drug induced liver injury: An update;Garcia-Cortes;Arch Toxicol,2020